Literature DB >> 11519486

Adenovirus vector-directed expression of the neurotrophin-3 receptor (TrkC) in mouse astrocytes.

N Rubio1, J Abad-Rodriguez.   

Abstract

In the present article we report the generation of a neurovirological reagent, an adenovirus vector that efficiently delivers the gene for the Neurotrophin-3 (NT-3) receptor, TrkC. Using this AdTrkC vector, we examined the induction of the expression of the above neurotrophin receptor in pure cultures of mouse astrocytes, a glial cell type that does not constitutively express this gene. Infection of astrocytes at an optimal dose of 100-200 plaque forming units (p.f.u.) per cell, induced expression of specific mRNA, as demonstrated by RT-PCR and Northern blot. This mRNA was translated to produce a mean of 20,157 biologically active receptor molecules per astrocyte with a Kd of 4.1 x 10(-11) M, as demonstrated by 125I-NT-3 binding. After 2D electrophoresis, the mature glycoprotein and some precursors were recognised by antibodies raised against the carboxy-terminal peptide of Trk. Binding of the ligand induced autophosphorylation ofTrkC and 3H-thymidine incorporation in transduced cells. These results demonstrate that our AdTrkC vector efficiently mediates the expression of high-levels of biologically active NT-3 receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519486     DOI: 10.1080/135502801300069755

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  44 in total

1.  The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3.

Authors:  C Cordon-Cardo; P Tapley; S Q Jing; V Nanduri; E O'Rourke; F Lamballe; K Kovary; R Klein; K R Jones; L F Reichardt
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

2.  Adenoviral vector-directed expression of neurotrophin-3 in rat dorsal root ganglion explants results in a robust neurite outgrowth response.

Authors:  P A Dijkhuizen; W T Hermens; M A Teunis; J Verhaagen
Journal:  J Neurobiol       Date:  1997-08

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  A model system for in vivo gene transfer into the central nervous system using an adenoviral vector.

Authors:  B L Davidson; E D Allen; K F Kozarsky; J M Wilson; B J Roessler
Journal:  Nat Genet       Date:  1993-03       Impact factor: 38.330

5.  Theiler's murine encephalomyelitis virus-binding activity on neural and non-neural cell lines and tissues.

Authors:  N Rubio; C De Felipe; C Torres
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

6.  TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.

Authors:  M A Grotzer; A J Janss; K Fung; J A Biegel; L N Sutton; L B Rorke; H Zhao; A Cnaan; P C Phillips; V M Lee; J Q Trojanowski
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

7.  Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.

Authors:  P Yeh; J F Dedieu; C Orsini; E Vigne; P Denefle; M Perricaudet
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents.

Authors:  P Ernfors; K F Lee; J Kucera; R Jaenisch
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

9.  Astrocytes infected with replication-defective adenovirus containing a secreted form of CNTF or NT3 show enhanced support of neuronal populations in vitro.

Authors:  G M Smith; J Hale; E M Pasnikowski; R M Lindsay; V Wong; J S Rudge
Journal:  Exp Neurol       Date:  1996-05       Impact factor: 5.330

10.  Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain-derived neurotrophic factor.

Authors:  A Rodríguez-Tébar; G Dechant; R Götz; Y A Barde
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.